Fn is implicated in the progression of advanced colorectal carcinoma and associated with clinical and molecular features, such as the proximal tumor location, BRAF mutation, MSI-high status, downregulating of antitumor T cell-mediated adaptive immunity, CRC staging, and a worse patient prognosis [14,19,20,21,22]. This evidence concerns the gene BRAF and colorectal carcinoma.